Cholinesterase Inhibitor Reveals Synergistic Potential for Neural Stem Cell-Based Therapy in the 5xFAD Mouse Model of Alzheimer’s Disease
Cheng-Chun Wu, Yung-Kuo Lee, Jui-Kang Tsai, Yu-Ting Su, Yu-Cheng Ho, Tian-Huei Chu, Kuang-Ti Chen, Chen-Lin Chang, Jui-Shen Chen · 2024
Read Cholinesterase Inhibitor Reveals Synergistic Potential for Neural Stem Cell-Based Therapy in the 5xFAD Mouse Model of Alzheimer’s Disease by Cheng-Chun Wu, Yung-Kuo Lee, Jui-Kang Tsai, Yu-Ting Su, Yu-Cheng Ho, Tian-Huei Chu, Kuang-Ti Chen, Chen-Lin Chang, Jui-Shen Chen (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11625195.txt.
Description
Cheng-Chun Wu and colleagues combine a common Alzheimer drug with stem cell grafts in mice. Their study from twenty twenty-four uses a genetic Alzheimer model. Stem cells alone show promise but survive poorly after transplant. Donepezil, a standard symptom drug, might help grafts thrive.
Stem cells were injected into the memory centre of mouse brains. Donepezil or placebo followed for one month afterwards. Grafted cells survived better and matured more with the drug. New connections formed between graft and host brain. Memory tests showed the model mice were impaired at baseline. Combination therapy outperformed either element alone in the readouts. Drug-plus-cell strategies deserve wider testing in brain repair.
Catalog record
| CREATOR | Cheng-Chun Wu, Yung-Kuo Lee, Jui-Kang Tsai, Yu-Ting Su, Yu-Cheng Ho, Tian-Huei Chu, Kuang-Ti Chen, Chen-Lin Chang, Jui-Shen Chen |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |